Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| LILRB4 | LILRB4-HB001 | Human | HEK293 | Non-biotinylated Human LILRB4/CD85k/ILT3 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB4 (22–257) AviHis |
| WT-1 | WT1-HP005 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &B2M&WT-1 (RMFPNAPYL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg | WT-1 (25–206) AviHis |
| WT-1 | WT1-HP006 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &B2M&WT-1 (RMFPNAPYL) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg | WT-1 (25–206) AviHis |
| WT-1 | WT1-HP007 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &mB2M&WT-1 (RMFPNAPYL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | WT-1 (25–206) His |
| LILRB1 | LILRB1-HP004 | Human | HEK293 | Human LILRB1/CD85j/ILT2 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB1 (24–458) mFcFc |
| HLA-A*03:01 | HLAA0301-HB002 | Human | E.coli | Biotinylated Human HLA-A*03:01&B2M&Influenza NP (ILRGSVAHK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*03:01 (25–305) AviHis |
| P53 R175H | P53R175H-HP006 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &mB2M&P53 R175H (HMTEVVRHC) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg | P53 R175H (25–206) AviHis |
| FcRn | FCRN-CB001 | Cynomolgus | HEK293 | Biotinylated Cynomolgus/Rhesus macaque FcRn Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | FcRn (24–297) AviFcHis |
| HLA-G | HLAG-HP001 | Cynomolgus | HEK293 | Cynomolgus HLA-G&B2M&Peptide (RIIPRHLQL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-G (25–305) AviHis |
| PRAME | PRAME-HB002 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&PRAME (ALYVDSLFFL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | PRAME (25–305) AviHis |
| HLA-G | HLAG-HP003 | Cynomolgus | HEK293 | HLA-G (25–305) AviHis | |
| LILRB1 | LILRB1-HB001 | Human | HEK293 | Non-biotinylated Human LILRB1/CD85j/ILT2 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB1 (24–458) AviHis |
| SARS-CoV-2 epitope | SCOV2EPI-HB001 | Human | HEK293 | Biotinylated Human HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | SARS-CoV-2 epitope (21–301) AviHis |
| KRAS G12A | KRASG12A-HP001 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12A (25–305) AviHis |
| HLA-G | HLAG-HB001 | Cynomolgus | HEK293 | Biotinylated Cynomolgus HLA-G&B2M&Peptide (RIIPRHLQL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-G (25–305) AviHis |
| p53 WT | P53WT-HP001 | Human | E.coli | Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | p53 WT (25–305) AviHis |
| WT-1 | WT1-HP004 | Human | E.coli | WT-1 (25–305) AviHis | |
| EGFR WT | EGFRWT-HP002 | Human | HEK293 | Human HLA-A*11:01&B2M&EGFR WT (KITDFGLAK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | EGFR WT (25–305) AviHis |
| PRAME | PRAME-HB004 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | PRAME (25–305) AviHis |
| KRAS G12V | KRASG12V-HP013 | Human | E.coli | FITC-Labeled Human HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 100 μg | KRAS G12V (25–305) AviHis |